(3S,4R,5S,6R,8S,9R,10S,13R,14S,15R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,4,6,8,15-pentol
Internal ID | 188fcc71-744d-40a1-823a-c456d6ea22f0 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Bile acids, alcohols and derivatives > Hydroxy bile acids, alcohols and derivatives |
IUPAC Name | (3S,4R,5S,6R,8S,9R,10S,13R,14S,15R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,4,6,8,15-pentol |
SMILES (Canonical) | CC(CCC(C(C)(C)O)O)C1CC(C2C1(CCC3C2(CC(C4C3(CCC(C4O)O)C)O)O)C)O |
SMILES (Isomeric) | C[C@H](CC[C@H](C(C)(C)O)O)[C@H]1C[C@H]([C@@H]2[C@@]1(CC[C@H]3[C@]2(C[C@H]([C@@H]4[C@@]3(CC[C@@H]([C@@H]4O)O)C)O)O)C)O |
InChI | InChI=1S/C27H48O7/c1-14(6-7-20(31)24(2,3)33)15-12-17(29)23-25(15,4)11-9-19-26(5)10-8-16(28)22(32)21(26)18(30)13-27(19,23)34/h14-23,28-34H,6-13H2,1-5H3/t14-,15-,16+,17-,18-,19-,20-,21+,22+,23-,25-,26-,27+/m1/s1 |
InChI Key | HXDUGHMQOCBJOT-PFYNCICHSA-N |
Popularity | 1 reference in papers |
Molecular Formula | C27H48O7 |
Molecular Weight | 484.70 g/mol |
Exact Mass | 484.34000387 g/mol |
Topological Polar Surface Area (TPSA) | 142.00 Ų |
XlogP | 1.50 |
Atomic LogP (AlogP) | 1.58 |
H-Bond Acceptor | 7 |
H-Bond Donor | 7 |
Rotatable Bonds | 5 |
(24R)-5alpha-cholestane-3beta,4beta,6beta,8,15beta,24,25-heptaol |
![2D Structure of (3S,4R,5S,6R,8S,9R,10S,13R,14S,15R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,4,6,8,15-pentol 2D Structure of (3S,4R,5S,6R,8S,9R,10S,13R,14S,15R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,4,6,8,15-pentol](https://plantaedb.com/storage/docs/compounds/2023/07/24r-5alpha-cholestane-3beta4beta6beta815beta2425-heptaol.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9572 | 95.72% |
Caco-2 | - | 0.7859 | 78.59% |
Blood Brain Barrier | + | 0.6000 | 60.00% |
Human oral bioavailability | + | 0.6143 | 61.43% |
Subcellular localzation | Mitochondria | 0.5498 | 54.98% |
OATP2B1 inhibitior | - | 0.5811 | 58.11% |
OATP1B1 inhibitior | + | 0.8890 | 88.90% |
OATP1B3 inhibitior | + | 0.9456 | 94.56% |
MATE1 inhibitior | - | 1.0000 | 100.00% |
OCT2 inhibitior | - | 0.9000 | 90.00% |
BSEP inhibitior | - | 0.7428 | 74.28% |
P-glycoprotein inhibitior | - | 0.5911 | 59.11% |
P-glycoprotein substrate | + | 0.5462 | 54.62% |
CYP3A4 substrate | + | 0.6968 | 69.68% |
CYP2C9 substrate | + | 0.5955 | 59.55% |
CYP2D6 substrate | - | 0.7294 | 72.94% |
CYP3A4 inhibition | - | 0.8761 | 87.61% |
CYP2C9 inhibition | - | 0.8613 | 86.13% |
CYP2C19 inhibition | - | 0.7934 | 79.34% |
CYP2D6 inhibition | - | 0.9643 | 96.43% |
CYP1A2 inhibition | - | 0.8083 | 80.83% |
CYP2C8 inhibition | - | 0.7168 | 71.68% |
CYP inhibitory promiscuity | - | 0.9417 | 94.17% |
UGT catelyzed | - | 0.5000 | 50.00% |
Carcinogenicity (binary) | - | 0.8900 | 89.00% |
Carcinogenicity (trinary) | Non-required | 0.7213 | 72.13% |
Eye corrosion | - | 0.9911 | 99.11% |
Eye irritation | - | 0.9420 | 94.20% |
Skin irritation | + | 0.5582 | 55.82% |
Skin corrosion | - | 0.9202 | 92.02% |
Ames mutagenesis | - | 0.7078 | 70.78% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.3973 | 39.73% |
Micronuclear | - | 0.9500 | 95.00% |
Hepatotoxicity | - | 0.6550 | 65.50% |
skin sensitisation | - | 0.7640 | 76.40% |
Respiratory toxicity | + | 0.6444 | 64.44% |
Reproductive toxicity | + | 0.9444 | 94.44% |
Mitochondrial toxicity | + | 0.9250 | 92.50% |
Nephrotoxicity | - | 0.8158 | 81.58% |
Acute Oral Toxicity (c) | III | 0.3855 | 38.55% |
Estrogen receptor binding | + | 0.6610 | 66.10% |
Androgen receptor binding | + | 0.6581 | 65.81% |
Thyroid receptor binding | + | 0.5795 | 57.95% |
Glucocorticoid receptor binding | + | 0.6498 | 64.98% |
Aromatase binding | + | 0.6461 | 64.61% |
PPAR gamma | + | 0.5656 | 56.56% |
Honey bee toxicity | - | 0.7389 | 73.89% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | - | 0.6600 | 66.00% |
Fish aquatic toxicity | + | 0.9564 | 95.64% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.91% | 97.25% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.25% | 96.09% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 95.76% | 95.58% |
CHEMBL2581 | P07339 | Cathepsin D | 94.93% | 98.95% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.24% | 91.11% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 93.99% | 97.79% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 93.98% | 96.61% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 92.53% | 95.93% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 92.09% | 97.09% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 90.94% | 98.05% |
CHEMBL237 | P41145 | Kappa opioid receptor | 90.79% | 98.10% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 89.90% | 95.89% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 89.73% | 82.69% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 88.56% | 100.00% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 88.22% | 100.00% |
CHEMBL4482 | O96013 | Serine/threonine-protein kinase PAK 4 | 88.00% | 95.42% |
CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 87.94% | 88.81% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.41% | 97.14% |
CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 87.38% | 85.31% |
CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 87.33% | 92.50% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 86.79% | 96.77% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 86.58% | 96.47% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 86.42% | 97.29% |
CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 86.35% | 92.86% |
CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 86.02% | 99.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 85.86% | 94.45% |
CHEMBL204 | P00734 | Thrombin | 85.57% | 96.01% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.12% | 100.00% |
CHEMBL4581 | P52732 | Kinesin-like protein 1 | 84.50% | 93.18% |
CHEMBL236 | P41143 | Delta opioid receptor | 84.47% | 99.35% |
CHEMBL233 | P35372 | Mu opioid receptor | 84.21% | 97.93% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.06% | 95.89% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.96% | 100.00% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 83.95% | 85.14% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 83.63% | 91.03% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.14% | 93.56% |
CHEMBL1902 | P62942 | FK506-binding protein 1A | 81.90% | 97.05% |
CHEMBL1871 | P10275 | Androgen Receptor | 81.77% | 96.43% |
CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 81.37% | 94.78% |
CHEMBL4302 | P08183 | P-glycoprotein 1 | 81.12% | 92.98% |
CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 81.07% | 87.16% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 80.84% | 98.33% |
CHEMBL2959 | Q08881 | Tyrosine-protein kinase ITK/TSK | 80.70% | 95.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Fraxinus ornus |
PubChem | 44566288 |
NPASS | NPC252065 |
LOTUS | LTS0195553 |
wikiData | Q105034939 |